[1]
L. Nagaraj and N. K. Madalageri, “A comparative study of metabolic side effects of risperidone and olanzapine in the treatment of schizophrenia”, Int J Basic Clin Pharmacol, vol. 8, no. 11, pp. 2561–2565, Oct. 2019.